INTRACEUTICS
DEAD

Serial Number

87245461

Owner

Endoceutics, Inc.

Attorney

Michael J. Leonard

Filing Date

Nov 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

INTRACEUTICS Trademark

Serial Number: 87245461

INTRACEUTICS is a trademark filed by Endoceutics, Inc. on November 22, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Endoceutics, Inc. (7 trademarks)

2989, rue de la Promenade
Quebec City G1W2J5 , CA

Entity Type: 03

Trademark Details

Filing Date

November 22, 2016

Registration Date

Not Registered

Goods & Services

Pharmaceutical educational services and patient educational services, namely, providing classes, workshops and seminars in the fields of treatment and prevention of cancer and endocrine-related disorders and diseases

Custom manufacture of pharmaceutical products to the order and specification of others

Pharmaceutical preparations and substances for the prevention and treatment of menopause, sexual dysfunction, vaginal atrophy, decreased libido, gynaecological disorders affecting menstruation, premenstrual syndrome, sterility, menstrual syndromes, dysmenorrhea, infertility, genital tract infections, pelvic inflammatory diseases, endometriosis, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities; pharmaceutical preparations and substances for the prevention and treatment of menopausal problems, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, breast pain; pharmaceutical preparations and substances for the prevention and treatment of the endocrine system; pharmaceutical preparations and substances for the prevention and treatment of oily skin, acne, male baldness; pharmaceutical preparations and substances for the prevention and treatment of prostate cancer and benign prostate enlargement; pharmaceutical preparations and substances for the prevention and treatment of obesity, high cholesterol, diabetes, loss of muscle mass and strength, bone loss

Wholesale distributorship of pharmaceuticals for others

Research and development in the field of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; laboratory research in the fields of treatment and prevention of cancer and endocrine-related disorders and diseases

Filing History

ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Jul 3, 2017 MAB1
ABANDONMENT - EXPRESS MAILED
Jul 3, 2017 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Jun 30, 2017 EXAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2016 NWOS
NEW APPLICATION ENTERED
Nov 25, 2016 NWAP